Piero Portincasa IG

Idioma: Ingles.
Referencias bibliográficas: 6
Paginas: 300-302
Archivo PDF: 129.38 Kb.

FRAGMENTO

Sin resumen

REFERENCIAS (EN ESTE ARTÍCULO)

1. Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V, Fontaine H, et al. FIB4: an inexpensive and accurate marker of fibrosis in HCV infection: Comparison with liver biopsy and fibrotest. Hepatology 2007; 46: 32-6.

2. Shaheen AA, Myer RP. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systemic review. Hepatology 2007; 46: 912-21.

3. Brunt EM, Wong VWS, Nobili V, Day CP, Sookoian S, Maher JJ, Bugianesi E, et al. Nonalcoholic fatty liver disease. Nature Reviews Disease Primers 2015: 15080.

4. Krawczyk M, Portincasa P, Lammert F. PNPLA3-associated steatohepatitis: toward a gene-based classification of fatty liver disease. Semin Liver Dis 2013; 33:369-79. Doi: 10.1055/s-0033-1358525.

5. Telfer PT, Prestcott E, Holden S, Walker M, Hoffbrand AV, Wonke B. Hepatic iron concentration combined with long term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major. Br J Haematol 2000; 110: 971-7.

6. Mirault T, Lucidarme D, Turlin B, Vandevenne P, Gosset P, Ernst O, Rose C. Non-invasive assessment of liver fibrosis by transient elastography in post transfusional iron overload. Eur J Haematol 2008; 80: 337-40.